)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Enlivex Therapeutics (ENLV) investor relations material
Enlivex Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary29 Aug, 2025
Executive summary
Positive three-month topline data from a Phase I/II trial of Allocetra in moderate-to-severe knee osteoarthritis showed significant improvements in pain and function, with a favorable safety profile.
Focus shifted to inflammatory and autoimmune indications, with sepsis and oncology programs now candidates for external collaboration or out-licensing.
Workforce reduced by 50% over the past year to align with reprioritized clinical focus.
Financial highlights
Net loss for the six months ended June 30, 2025 was $5.3M, down 26% year-over-year; Q2 net loss was $1.87M, down 40% year-over-year.
Operating loss for the six months was $6.6M, a 7% decrease from the prior year; Q2 operating loss was $3.08M, up 3% year-over-year.
Finance income for the six months was $1.29M, up from a $99K loss in the prior year, driven by interest income and favorable FX movements.
Cash and cash equivalents plus short-term deposits totaled $19.5M as of June 30, 2025.
Net cash used in operations for the six months was $5.82M, down from $6.31M in the prior year.
Outlook and guidance
Existing resources expected to fund operations through the end of 2026, including planned clinical milestones.
Additional funding will be required for further development, regulatory approval, and commercialization.
Next steps for Allocetra's OA program?
Funding strategy beyond current runway?
Sepsis/oncology out-licensing strategy impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Enlivex Therapeutics earnings date
Q1 202523 Oct, 2025
Next Enlivex Therapeutics earnings date
Q1 202523 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Enlivex Therapeutics Ltd is an Israel-based clinical-stage biopharmaceutical company focused on developing allogeneic cell therapies for life-threatening immune-related diseases. The company’s lead investigational product is designed to modulate the immune system to restore immune balance in conditions such as sepsis, solid tumors, and other inflammatory disorders. Enlivex conducts clinical trials and research to advance its immunotherapy platform. The company is headquartered in Nes Ziona, Israel, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage